U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07164131) titled 'Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia' on Aug. 20.
Brief Summary: The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
Community-acquired Pneumonia
Intervention:
DRUG: Doxycycline
Subjects will receive Doxycycline (orally or intravenously) in combination with beta-lactam therapy within 12 hours of hospital admission. Treatment duration will be 5-7 days.
DRUG: ...